Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk After Initial Treatment in Patients With Non-metastatic Breast Cancer

NCT05049031 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT05049031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05049031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk After Initial Treatment in Patients With Non-metastatic Breast Cancer
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
October 6, 2021
Completion date
February 1, 2022
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer